Cargando…
Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial
INTRODUCTION: Obesity drives type 2 diabetes (T2DM) development. Laparoscopic adjustable gastric banding (LAGB) has lower weight reduction than other bariatric procedures. Liraglutide, a GLP-1 receptor agonist, improves weight and glycaemic control in patients with T2DM. This study aimed to determin...
Autores principales: | Coelho, Claudia, Dobbie, Laurence J., Crane, James, Douiri, Abdel, Learoyd, Annastazia E., Okolo, Olanike, Panagiotopoulos, Spyros, Pournaras, Dimitri J., Ramar, Sasindran, Rubino, Francesco, Singhal, Rishi, le Roux, Carel W., Taheri, Shahrad, McGowan, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599987/ https://www.ncbi.nlm.nih.gov/pubmed/37696925 http://dx.doi.org/10.1038/s41366-023-01368-4 |
Ejemplares similares
-
Revisiting ethnic discrepancies in Covid-19 hospitalised cohorts: a correction for collider bias
por: Learoyd, Annastazia E., et al.
Publicado: (2023) -
The pain trajectory of juvenile idiopathic arthritis (JIA): translating from adolescent patient report to behavioural sensitivity in a juvenile animal model
por: Learoyd, Annastazia E., et al.
Publicado: (2019) -
Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial
por: Papamargaritis, Dimitris, et al.
Publicado: (2020) -
Liraglutide: another reason to target prediabetes?
por: Murphy, Conor F., et al.
Publicado: (2017) -
Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili, Heshma, et al.
Publicado: (2021)